Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2001

Dong Y, Kaushal A, Bui L, Chu S, Fuller P J, Nicklin J, Samaratunga H, Clements J A

Abstract excerpt

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor marker. The aim of this study was to examine the expression of KLK4 in the normal ovary and ovarian tumors of different histology, stage, and differentiation and to determine its association with ovarian tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Western
Share to DNA, Complementary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estradiol

Share to In Situ Hybridization

Share to Kallikreins

Share to Ovarian Neoplasms

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 11489814

Genes

KLK4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.PMID 11489814Read ↗

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.Semantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerSemantic proximity Read ↗

Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevanceSemantic proximity Read ↗

Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate CancerSemantic proximity Read ↗

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.Semantic proximity Read ↗

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapySemantic proximity Read ↗

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.Semantic proximity Read ↗

Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.Semantic proximity Read ↗

Expression Profiling of the Ovarian Surface Kinome Reveals Candidate Genes for Early Neoplastic ChangesSemantic proximity Read ↗

Identification and Characterization of KLK-L4, a New Kallikrein-like Gene That Appears to be Down-regulated in Breast Cancer TissuesSemantic proximity Read ↗

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.